Drug

Doxorubicin clinical trials

Also written Adriamycin, Rubex, hydroxydaunorubicin and FI 106.

Includes 237 studies of Liposomal doxorubicin.

studies test it: 842
open now: 91
in phase 3: 142
first study started: 1990

Keep track of what changes. Save the Doxorubicin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Doxorubicin: 279
doxorubicin hydrochloride: 204
Adriamycin PFS: 66
Adriamycin RDF: 65
ADM: 59

Brand

Adriamycin: 169
Rubex: 55
Adriblastina: 32
Doxil: 8
Myocet: 6
Caelyx: 1

Development codes

FI 106: 32
NSC-123127: 5

Other names

hydroxydaunorubicin: 41
ADRIAMYCIN, HYDROCHLORIDE: 32
Adriablastin: 22
Hydroxydaunomycin hydrochloride: 4

Written with another drug

CHOP: 18
ABVD: 6
doxorubicin and cisplatin: 2
Adriamycin/Cytoxan: 2

Studies by the year they started

831 studies that test it; most in 2008 (51)

Studies that test Doxorubicin, by start year
Year	Studies
1990	1
1992	4
1993	2
1994	7
1995	7
1996	9
1997	15
1998	20
1999	19
2000	22
2001	20
2002	25
2003	34
2004	43
2005	36
2006	49
2007	41
2008	51
2009	42
2010	30
2011	21
2012	28
2013	27
2014	19
2015	27
2016	31
2017	23
2018	21
2019	36
2020	14
2021	16
2022	25
2023	18
2024	15
2025	18
2026	15

By phase

A phase 1/2 study counts in both.

Early Phase 1: 8
Phase 1: 212
Phase 2: 513
Phase 3: 142
Phase 4: 21
No phase: 32

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 170
Sarcoma: 74
Multiple Myeloma: 42
Ovarian Neoplasms: 38
Lymphoma: 31
Hodgkin Disease: 27
Precursor Cell Lymphoblastic Leukemia-Lymphoma: 26
Lymphoma, Large B-Cell, Diffuse: 25
Carcinoma, Hepatocellular: 19
Carcinoma, Ovarian Epithelial: 17
Prostatic Neoplasms: 17
Triple Negative Breast Neoplasms: 16

Who runs them

Industry 141 · Other 701

National Cancer Institute (NCI) (49) · M.D. Anderson Cancer Center (38) · Children's Oncology Group (28) · Memorial Sloan Kettering Cancer Center (20) · St. Jude Children's Research Hospital (14) · University of Washington (13) · Gynecologic Oncology Group (12) · European Organisation for Research and Treatment of Cancer - EORTC (11)

Often tested with

Tested in the same studies.

Cyclophosphamide (279) · Vincristine (158) · Prednisone (106) · Etoposide (99) · Paclitaxel (93) · Cisplatin (81) · Dexamethasone (74) · Ifosfamide (69)

Studies

Open first, then newest update. How each study uses Doxorubicin is read from its arms, and is right about nine times in ten.

Testing it · 842

See all 842 studies that test Doxorubicin →

Given in every arm · 628 — Doxorubicin is usual care beside what is tested

Showing 20 of 628.

As the comparator · 121 — what is tested is compared with Doxorubicin

Showing 20 of 121.

Codes

What other systems call Doxorubicin · ClinicalTrials.gg INT007399

MeSH (NLM) D004317DoxorubicinConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) 80168379AGDOXORUBICINConfirmed FDA, NLM, Wikidata
RxNorm 3639Confirmed FDA, Wikidata
Wikidata Q18936doxorubicinConfirmed FDA, NLM, Wikidata
NCI Thesaurus C456DoxorubicinOne source FDA
DrugBank DB00997One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D004317	Doxorubicin	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	80168379AG	DOXORUBICIN	Confirmed FDA, NLM, Wikidata
RxNorm	3639	—	Confirmed FDA, Wikidata
Wikidata	Q18936	doxorubicin	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C456	Doxorubicin	One source FDA
DrugBank	DB00997	—	One source Wikidata

Also registered as doxorubicin citrate (UNII AJQ2ZNG2WL) and doxorubicin hydrochloride (UNII 82F2G7BL4E · RxNorm 142433).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.